How to Become the Next Teslanaire
Are you a Teslanaire?
This is a new term that describes investors who bought early shares of Tesla (NASDAQ: TSLA) and became millionaires in the process.
If you bought 1,000 shares of Tesla right after it went public at around $25 per share - back when I told investors it would be a wise investment - you might be a Teslanaire.
To be exact, those initial 1,000 shares would've been worth more than $1 million after the stock exceeded $1,000 per share.
How many people do you know who have ever had the opportunity to turn $25,000 into $1 million?
Better yet, how many times have you had the opportunity to turn $25,000 into $1 million?
Although Tesla has long been a punching bag for career short sellers and people who still believe the internal combustion engine is NOT an outdated technology, those who took a chance on the electric vehicle startup early on made a fortune.
Of course, in the world of investing, Tesla's success is not the norm.
Truth is, most folks go their entire lives without ever pulling in a gain anywhere close to what Tesla has delivered over the past 10 years.
But that doesn't mean it's impossible.
In fact, as we head into 2021, you'll definitely have an opportunity to get an early piece of the next "big thing" that could ultimately make those Tesla gains look like peanuts.
Welcome to the Wonderful World of Psychedelics
I first started writing about the psychedelics market about two years ago when there wasn't a single publicly traded psychedelics company out there.
Today, there are dozens, and by the end of the year, there will be in excess of 50 pure plays in the space.
Of course, most will be garbage, as is the case anytime a new, vibrant market enters the arena. But if you can bag a few good ones - the best in breed - you could also easily pull in the types of gains that Teslanaires pulled in... and probably in a much shorter time frame.
MindMed (OTCBB: MMEDF) is certainly an excellent example.
This psychedelics company went public back in early 2020, and I recommended that investors get in below $0.40 a share.
By early December, the stock traded in excess of $5.00 a share.
That's a gain of around 1,200% - inside a single year.
Of course, the stock has sold off a bit since then, but mark my words: 2021 is going to be a very profitable year for MindMed investors, as well as investors who are jumping on the right psychedelics stocks now.
The Best Free Investment You'll Ever Make Our analysts have traveled the world over, dedicated to finding the best and most profitable investments in the global energy markets. All you have to do to join our Energy and Capital investment community is sign up for the daily newsletter below.
This Is Going to Be HUGE!
If you're a regular reader of these pages, you already know that I made a ton of money on Tesla.
I also made a ton of money in the cannabis space - before the bottom dropped out of that market.
Take Canopy Growth Corporation (TSX: WEED), for instance.
I recommended that investors buy shares of this stock back in 2015 when it was trading for just $1.60 a share.
On October 15, 2018, the stock reached an all-time high of $74.00 a share.
That's a gain of 4,525%.
A one-time investment of just $5,000 turned into more than $230,000!
That's nearly a quarter of a million dollars from just five grand.
Of course, I sold long before then, recommending investors unload their shares at $50.
Still, that resulted in a gain of more than 3,000%, which turned every $5,000 into more than $150,000.
Not bad at all.
But compared with what we're going to see in the psychedelics market in 2021, that 3,000% we pulled in on Canopy Growth will look like chump change.
Look, I've been doing this for a long time.
More than 30 years now.
I've helped investors make millions in the renewable energy space, the biotech space, and the cannabis space.
But nothing has ever looked more profitable to me than the burgeoning psychedelics market.
Of course, don't just take my word for it.
Just look at the numbers yourself in this white paper I put together, which not only explains why I'm so bullish on the psychedelics market but also gives you some insight on the psychedelics companies I'm investing in now.
To a new way of life and a new generation of wealth... Jeff Siegel Jeff is the founder and managing editor of Green Chip Stocks, a private investment community that capitalizes on opportunities in alternative energy, organic food markets, legal cannabis, and socially responsible investing. He has been a featured guest on Fox, CNBC, and Bloomberg Asia, and is the author of the best-selling book, Investing in Renewable Energy: Making Money on Green Chip Stocks. For more on Jeff, go to his editor's page.
@JeffSiegel on Twitter